Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zura Bio Limited - Class A Ordinary shares
(NQ:
ZURA
)
3.570
+0.020 (+0.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
194,037
Open
3.590
Bid (Size)
3.320 (2)
Ask (Size)
3.700 (9)
Prev. Close
3.550
Today's Range
3.520 - 3.680
52wk Range
2.000 - 7.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
August 13, 2024
ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 13, 2024
From
Zura Bio Limited
Via
Business Wire
Performance
YTD
-17.93%
-17.93%
1 Month
-5.31%
-5.31%
3 Month
-32.00%
-32.00%
6 Month
-2.46%
-2.46%
1 Year
-48.11%
-48.11%
More News
Read More
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants
August 12, 2024
From
Zura Bio Limited
Via
Business Wire
ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024
May 09, 2024
Via
InvestorPlace
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants
August 09, 2024
From
Zura Bio Limited
Via
Business Wire
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
August 01, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
3 Undervalued Biotech Stocks With Breakout Potential
July 19, 2024
Via
InvestorPlace
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation
July 12, 2024
From
Zura Bio Limited
Via
Business Wire
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
June 14, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
June 06, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
June 03, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Participation in June Investor Conferences
May 29, 2024
From
Zura Bio Limited
Via
Business Wire
3 Penny Stocks to Buy Now: May 2024
May 24, 2024
Via
InvestorPlace
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Zura Bio Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
April 18, 2024
From
Zura Bio
Via
Business Wire
Zura Bio Announces Robert Lisicki as CEO and Director
April 08, 2024
From
Zura Bio Limited
Via
Business Wire
ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
March 28, 2024
From
Zura Bio Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
March 22, 2024
Via
Benzinga
Zura Bio Announces Participation at March Conferences
March 04, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Participation at February Investor Conferences
February 02, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
January 08, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
January 03, 2024
From
Zura Bio Limited
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.